HC Wainwright Reiterates Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)
HC Wainwright reissued their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $69.00 price objective on the stock. Other analysts also recently issued reports about the stock. Bank of America increased their price target on shares of Rhythm Pharmaceuticals from $48.00 […]
More Stories
7 Best Delivery Apps to Make Money in 2025
In the current fast-paced world, side hustles have become an increasingly popular means of earning extra cash, specifically, food delivery...
NorthCrest Asset Manangement LLC Buys 4,007 Shares of Altria Group, Inc. (NYSE:MO)
NorthCrest Asset Manangement LLC increased its stake in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 88.5% in...
CVA Family Office LLC Reduces Stake in Phillips 66 (NYSE:PSX)
CVA Family Office LLC decreased its stake in shares of Phillips 66 (NYSE:PSX – Free Report) by 11.4% during the...
NorthCrest Asset Manangement LLC Lowers Stock Holdings in U.S. Bancorp (NYSE:USB)
NorthCrest Asset Manangement LLC trimmed its stake in U.S. Bancorp (NYSE:USB – Free Report) by 7.0% in the 1st quarter,...
1,170 Shares in Marsh & McLennan Companies, Inc. (NYSE:MMC) Purchased by NorthCrest Asset Manangement LLC
NorthCrest Asset Manangement LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report)...
Elevation Point Wealth Partners LLC Has $778,000 Stake in Adobe Inc. (NASDAQ:ADBE)
Elevation Point Wealth Partners LLC trimmed its stake in Adobe Inc. (NASDAQ:ADBE – Free Report) by 24.4% during the 1st...